AvalehtMEHCQ • OTCMKTS
add
Chrome Holding Co
Viimane sulgemishind
3,60 $
Tänane vahemik
3,45 $ - 3,57 $
Aasta vahemik
0,47 $ - 6,21 $
Turuväärtus
96,40 mln USD
Keskmine maht
125,12 tuh
P/E suhe
-
Dividendimäär
-
Põhibörs
OTCMKTS
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | juuni 2025info | Y/Y muutus |
|---|---|---|
Käive | 25,42 mln | −37,10% |
Põhitegevusega seonduv kulu | 44,24 mln | −43,21% |
Puhastulu | −23,83 mln | 65,67% |
Puhaskasumimarginaal | −93,74 | 45,41% |
Puhaskasum aktsia kohta | — | — |
EBITDA | −28,49 mln | 46,78% |
Tõhus maksumäär | — | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | juuni 2025info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 39,83 mln | −76,57% |
Kogu vara | 144,33 mln | −60,79% |
Kõik kohustused | 187,19 mln | −16,64% |
Kogu omakapital | −42,86 mln | — |
Emiteeritud aktsiate arv | 27,54 mln | — |
Hinna ja väärtuse suhe P/B | −2,31 | — |
Varade tasuvus | −50,47% | — |
Kapitali tasuvus | 438,85% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | juuni 2025info | Y/Y muutus |
|---|---|---|
Puhastulu | −23,83 mln | 65,67% |
Põhitegevuse rahakäive | −28,99 mln | 33,00% |
Investeeringute raha | −1,03 mln | 10,64% |
Finantseerimise raha | 24,28 mln | 269 711,11% |
Raha ja raha ekvivalentide muutus | −5,74 mln | 87,07% |
Tasuta rahavoog | 22,86 mln | 281,90% |
Teave
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Asutatud
apr 2006
Veebisait
Töötajate arv
261